Home » Consortium SMEs » BioSci Consulting BVBA, Belgium

BioSci Consulting BVBA, Belgium

Partner Description

At BioSci Consulting we believe that to accelerate healthcare innovation and narrow the translational gap we don’t need a handful of good leaders. We need a whole army of vision-driven leaders working together in bold collaborative endeavors such as consortia, stakeholder communities and innovation ecosystems. We make being a vision-driven leader easier by providing strategic planning, strategic project design and strategic guidance for collaborative endeavors. Our approach is focused on facilitating the interaction between different disciplines and stakeholders to generate creative ideas for solving problems and developing projects.

The BioSci team is fully aligned to the saying “if you want to go fast, go alone but if you want to go far, go with people” (African proverb). Thus, we are very excited to be part of the imSAVAR consortium and bringing forward experts from various fields such as immunology and cell therapy to drive forward innovation activities across the different areas of work and to ensure patients are involved in shaping the impact. In addition, we are committed to ensuring that the project is sustainable after the funding period through the BioPharma X Advanced Therapies (ATBX) translational ecosystem.

BioPharmaX is a membership community of experts from different fields across the R&D health sector with shared common interests. Through the BioPharmaX framework, members are able to work together solving problems as well as expanding their impact through multi-stakeholder collaborative programs.

The Advanced Therapies BioPharmaX (ATBX) translational ecosystem brings together experts from academia, industry, patient representatives and regulatory authorities with an interest in accelerating cell and gene therapy advances. See here for more details and we look forward to seeing you at the ATBX community!

Role within Project

  • Expertise and support in WP 1
  • Innovation management
  • Patient stakeholder involvement
  • Cross-initiative concertation activities
  • Sustainability planning